Treos Bio
London
About Treos Bio
Treos Bio, Inc. is a computational immunology and immunotherapy company which has developed a proprietary technology to predict in silico likely responders to cancer immunotherapies and to design in silico next generation targeted immunotherapies for a large population of cancer patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $26.5M
- Last round: Convertible Note (Aug 2025)
- Website: treosbio.com
- Phone: +44-20-3141 7370
Industries & Categories
Biotechnology, Clinical Trials, Health Care, Health Diagnostics, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/treos-bio-31774 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.